Methods for preparing deuterated compounds by photocatalysis and halogen atom catalysis
By using photocatalysis and halogen atom catalysis, and by activating CH bonds with halogen catalysts and deuterium water, highly efficient deuteration of amides and benzylic compounds was achieved. This solved the problems of expensive deuterium sources and poor selectivity in existing technologies, and improved the efficiency and applicability of deuteration reactions.
Patent Information
- Application Number
- CN202510622876.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-15
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies for preparing deuterated compounds, especially in the deuteration of amides and benign compounds, suffer from problems such as expensive deuterium sources, poor selectivity, and limited applicability, making it difficult to achieve efficient and economical deuteration reactions.
A photocatalytic and halogen atom catalytic method was adopted, using halogen catalysts such as NaBr or NiBr2·glyme, combined with deuterated water as a deuterium source, to activate CH bonds under light irradiation, achieving efficient deuteration at the N-α and benzylic positions of amides. The deuteration reaction was carried out by using halogen atoms as hydrogen atom transfer reagents (HAT).
It achieves deuteration reactions with high recovery and high deuteration rates, reaching approximately 90%, resulting in high product yields and wide applicability. It is suitable for the deuteration of various drug molecules, improving the biostability and pharmacokinetics of drugs.
Smart Images

Figure CN123106583A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of fine chemicals technology, specifically to a method for preparing deuterated compounds using photocatalysis and halogen atom catalysis. Background Technology
[0002] Deuterated compounds are compounds in which one or more hydrogen atoms (H) in the CH bonds are replaced with deuterium atoms (D). Despite rapid advancements in analytical techniques over the past 20 years, the introduction of isotope labeling remains an effective method for the in vivo and in vitro detection and quantification of drugs and drug metabolites. Due to the stability of deuterium atoms, deuteration of drug molecules can improve their metabolic stability, prolong their half-life, and reduce toxicity. Deuterium can also alter the binding affinity and selectivity of drugs to their targets, which can improve their therapeutic index and reduce off-target effects. Finally, deuterium is beneficial for improving drug solubility and formulation stability, thus facilitating dosage form preparation and administration. 1 Therefore, in general, introducing deuterium into drug molecules is expected to improve drug safety and enhance its efficacy and selectivity.
[0003] The preparation of deuterated compounds mainly involves methods such as dehalogenation of organic compounds, hydrogen-deuterium exchange, and hydrogenation of unsaturated double bonds. Currently, the main methods for studying the deuteration of amines and benzylic compounds are as follows:
[0004] (1) Transition metal-catalyzed hydrogen-deuterium exchange reaction:
[0005] Transition metal catalysis primarily works by activating the CH bond, thereby enabling isotopic exchange between the CH bond and deuterium or tritium. Several research groups have used Ir... 2 Ni 3 Ru 4,5 Pd 6 Metals have enabled the deuteration of amines and benign compounds. In recent years, Kerr's research group... 7 The developed iridium catalyst enables highly efficient and selective deuteration of indole and pyrrole N-heterocyclic compounds. This reaction uses deuterium gas as the deuterium source, which is relatively expensive. (Soloshonok research group) 3 The chiral deuteration of α-amino acid compounds using metallic Ni and ligands is limited by the types of substrates required for this reaction. (Gunanathan's research group) 5 The study reported the selective deuteration of amines using a Ru catalyst and D₂O, but the deuteration rate of most substrates was only around 80%. (Kiesling's group...) 6The study reported on the benzylic deuteration of Pd nanoparticles. The hydrogen-deuterium exchange reaction catalyzed by transition metals, using deuterium gas as the deuterium source, can effectively achieve the deuteration of amines and benzylic compounds. However, the expensive deuterium source and organometallic reagents limit its application range.
[0006] (2) Hydrogen-deuterium exchange reactions involving strong bases:
[0007] Zhang's research group 8 The report describes the use of the strong base potassium tert-butoxide and DMSO-d 6 The deuteration of amines and nitrogen-containing heterocycles is achieved through a reaction in which deprotonation of deuterated dimethyl sulfoxide (DMSO) is performed by potassium tert-butoxide, followed by further single-electron oxidation to form a radical. This radical then abstracts a benzylic α-CH group to generate the deuterated product. Although this method yields high product yields and deuteration rates, the deuteration of DMSO-d... 6 The method still needs further development because the reagents are expensive and cannot be used on a large scale.
[0008] (3) Light-mediated deuteration reaction:
[0009] In 2017, MacMillan's research group 9 A creative approach was developed to achieve N-αsp using photo-oxidation-reduction and HAT strategies. 3 CH deuteration, using excited-state trivalent iridium photosensitizers, involves the formation of an N-α carbon-centered radical from a single-electron oxidized amine substrate, followed by a HAT process with a tritium thiol to achieve tritation. This method is highly efficient and mild, and can achieve both deuteration and tritation of drug molecules. However, its substrates are mainly limited to alkylamines or aniline-type substrates, and it is not suitable for common amide substrates with higher oxidation potentials. Furthermore, the method has poor site selectivity. Therefore, this method warrants further research and development.
[0010] Hydrogen atom transfer (HAT) is an important elementary reaction in organic synthesis. It occurs via the inert but ubiquitous C(sp) atoms. 3 Using the H-bond as a radical precursor, photomediated HAT can directly achieve the controllable formation and precise transformation of carbon radicals under very mild conditions. Numerous electrophilic radical species (mainly nitrogen, oxygen, sulfur, and halogen heteroatom radicals) have been proven to act as HAT catalysts or reagents to activate electron-rich and electrically neutral C(sp) radicals. 3 -H key. From C(sp 3 There are very few reports on the direct realization of benzylic and N-α deuteration using )-H substrates as raw materials, especially the use of photocatalysis and HAT-activated radicals to achieve benzylic and N-α deuteration.
[0011] Therefore, nitrogen-containing compounds are an important component of drug molecules. This invention can significantly improve the activity of drug molecules by deuterating aniline, amide, and benzylic compounds, which is of great significance for drug molecule preparation and tracking metabolism. 3
[0012] (1) Di Martino, RMC; Maxwell, BD; Pirali, T. Deuteriumin drugdiscovery: progress, opportunities and challenges. Nat. Rev. DrugDiscovery 2023, 22(7), 562-584.
[0013] (2)Kerr, WJ; Mudd, RJ; Reid, M.; Atzrodt, J.; Derdau, V. Iridium-CatalyzedCsp3-H Activation for Mild and Selective Hydrogen Isotope Exchange.ACSCatal.2018,8(11),10895-10900.
[0014] (3) Takeda, R.; Abe, H.; Shibata, N.; Moriwaki, H.; Izawa, K.; Soloshonok, VAAsymmetric synthesis of α-deuteratedα-amino acids. Org. Biomol. Chem. 2017, 15(33), 6978-6983.
[0015] (4)Neubert, L.; Michalik, D.; S.; Imm, S.; Neumann, H.; Atzrodt, J.; Derdau, V.; Holla, W.; Beller, M.
[0016] Ruthenium-Catalyzed Selectiveα,β-Deuteration of BioactiveAmines.J.Am.Chem.Soc.2012,134(29),12239-12244.
[0017] (5)Chatterjee,B.;Krishnakumar,V.;Gunanathan,C.Selectiveα-DeuterationofAmines and Amino Acids Using D2O.Org.Lett.2016,18(22),5892-5895.
[0018] (6)Pfeifer,V.;Zeltner,T.;Fackler,C.;Kraemer,A.;Thoma,J.;Zeller,A.;Kiesling,R.Palladium Nanoparticles for the Deuteration and TritiationofBenzylic Positions on Complex Molecules.Angew.Chem.Int.Ed.2021,60(51),26671-26676.
[0019] (7)Brown,J.A.;Cochrane,A.R.;Irvine,S.;Kerr,W.J.;Mondal,B.;Parkinson,J.A.;Paterson,L.C.;Reid,M.;
[0020] Tuttle,T.;Andersson,S.;et al.The Synthesis ofHighly Active Iridium(I)Complexes and their Application in Catalytic Hydrogen IsotopeExchange.Adv.Synth.Catal.2014,356(17),3551-3562.
[0021] (8)Hu,Y.;Liang,L.;Wei,W.-t.;Sun,X.;Zhang,X.-j.;Yan,M.A convenientsynthesis of deuterium labeled amines and nitrogen heterocycles with KOt-Bu / DMSO-d6.Tetrahedron 2015,71(9),1425-1430.
[0022] (9)Loh, YY; Nagao, K.; Hoover, AJ; Hesk, D.; Rivera, NR; Colletti, SL; Davies, IW; MacMillan, DW
[0023] C.Photoredox-catalyzed deuteration and tritiation ofpharmaceuticalcompounds.Science 2017,358(6367),1182-1187. Summary of the Invention
[0024] In view of this, the inventors of this application have long been committed to the study of photocatalysis and halogen atom-catalyzed asymmetric functionalization reactions. They have found that halogen atoms are commonly used as HAT reagents to achieve the activation of amide or benzylic substrates. Therefore, based on the team's research, the inventors of this application propose to use halogen atoms as HAT reagents and deuterium sources (such as deuterated water) to achieve deuteration reactions at the N-α and benzylic positions of amides.
[0025] The method studied in this invention can be effectively used to develop various deuterated drug molecules to enhance biological stability and improve pharmacokinetics.
[0026] This invention provides a method for preparing deuterated compounds by photocatalysis and halogen atom catalysis, which achieves high recovery and high deuteration rate of aniline, amide and benzylic compounds under photocatalysis and halogen atom-mediated conditions. The method has high deuteration rate, good selectivity, high product yield and wide applicability.
[0027] To achieve the above objectives, the technical solution adopted by the present invention is specifically described as follows:
[0028] On one hand, the present invention provides a method for preparing deuterated compounds by photocatalysis and halogen atom catalysis, comprising the following steps:
[0029] Step S1: Add the photocatalyst, other catalysts, sulfur reagent, substrate, and solvent to a reactor equipped with magnetic particles;
[0030] Step S2: After adding the deuterium source, seal the reactor;
[0031] Step S3: Turn on the stirrer, heat the reactants to the reaction temperature, and react under light until the reaction is completed. After post-processing, the deuterated product is obtained.
[0032] The substrate is selected from
[0033] The deuterated product is selected from
[0034] The other catalysts are optionally absent, or selected from halogen catalysts or Ni catalysts;
[0035] Among them, R 1 Selected from alkyl, -C(=O)-R 5 、-(CR 6 2) n -O-aryl-O-aryl, -(CR 6 2) n -C(=O)-O-cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 ;
[0036] R 3 Selected from hydrogen, alkyl, -C(=O)-R 5 ;
[0037] Or R 1 and R 3 Together with the atoms attached to them, they form a heterocycle with 5 to 10 ring atoms, preferably a heterocycle with 5, 6, 7, 8, 9, or 10 ring atoms;
[0038] R 2 Selected from -C(=O)-R 5 -C(=O)OR 5 aryl, -C(=O)-NH-R 5 ;
[0039] R 6 Selected from hydrogen or alkyl;
[0040] n is an integer from 0 to 20;
[0041] R 4 Selected from haloalkyl, alkyl, -C(=O)-R 5 、-(CR 6 2) n -OH, -(CR) 6 2) n -C(=O)-OH、-(CR 6 2) n -C(=O)-NH-R 5 、-(CR 6 2) n -NH-C(=O)-R 5 -OC(=O)-R 5 、-(CR6 2) n -O-aryl-O-aryl, -(CR 6 2) n -C(=O)-O-cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 ;
[0042] Or R 4 It forms a ring of 5 to 15 ring atoms with the C atom on Ar;
[0043] The R 5 Selected from C 1-20 Alkyl, -CN, -O-alkyl, cycloalkyl, -NH-alkyl, -Ar-Ar, aryl or heteroaryl;
[0044] Ar is selected from aryl or heteroaryl;
[0045] The alkyl, heterocyclic, cyclic, cycloalkyl, aryl, and heteroaryl groups with 5 to 15 ring atoms may be further substituented with the same or different -R groups. 7 Mono- or poly-substituted, wherein the substituent R 7 Selected from hydrogen, deuterium, fluorine, chlorine, bromine, iodine, -CN, -OH, -C(=O)OH, -C(=O)-NH-alkyl, -NH-C(=O)-alkyl, haloalkyl, alkyl, -C(=O)O-alkyl, -(CR 6 2) n -C(=O)OH, -(CR) 6 2) n -C(=O)O-alkyl, -C(=O)-alkyl, -OC(=O)-alkyl, -O-alkyl, -B(pin), -OTBS, -C(=O)O-aryl, -C(=O)-aryl, -OC(=O)-aryl, -O-aryl, -NHC(=O)-aryl, aryl, aryl-OC(=O)-alkyl, aryl-C(=O)O-alkyl, heteroaryl-aryl-S(=O)2-NH2, heterocyclic or heteroaryl.
[0046] Furthermore, the substituent R 7 It can be further substituted by the same or different substituents.
[0047] Furthermore, the photocatalyst is an iridium photosensitizer. Further, the iridium photosensitizer is selected from Ir[dF(CF3)ppy]2(dtbbpy)PF6. The photocatalyst used in this invention is a common iridium photocatalyst, which is simple and readily available.
[0048] Furthermore, the halogen catalyst is selected from at least one of NaBr and NiBr2·glyme. The halogen catalyst used is readily available and can be used as a halogen atom precursor.
[0049] Furthermore, the Ni catalyst is NiBr2·glyme.
[0050] Further, the sulfur reagent is selected from disulfide or L-cysteine derivatives. Further, the sulfur reagent is selected from... (dimethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-acetamidopropanoate)), At least one of (1,2-bis(4-chlorophenyl)disulfane). An inexpensive and readily available disulfide is used as the sulfur reagent, or an L-cysteine derivative is used as the sulfur reagent.
[0051] Further, the solvent is selected from at least one of ethyl acetate, isopropyl acetate, ethanol, methanol, cyclohexane, n-hexane, n-pentane, n-heptane, petroleum ether, gasoline, diethyl ether, tetrahydrofuran, dichloromethane, chloroform, deuterated chloroform, carbon tetrachloride, 1,2-dichloroethane, ethyl acetate, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and deuterated acetonitrile.
[0052] Furthermore, in step S1, a ligand may optionally be added. Further, the ligand is selected from dtbbpy.
[0053] Furthermore, the deuterium source is selected from at least one of deuterium gas, deuterated water, deuterated iodomethane, deuterated methanol, deuterated ethanol, deuterated benzene, and deuterated lithium aluminum. The present invention preferably uses relatively inexpensive deuterated water as the deuteration reagent.
[0054] Furthermore, the illumination uses a 30-40W blue LED with a wavelength of 400-450nm, preferably 427nm.
[0055] Furthermore, the heating temperature is 50–90°C, preferably 60–80°C, and more preferably 60, 70, or 80°C.
[0056] Furthermore, the reaction time in step S3 is 48 to 72 hours, preferably 48, 50, 55, 60, 65, 70, or 72 hours.
[0057] Furthermore, the molar amount of the photocatalyst is 1–4 mol%.
[0058] Furthermore, the molar ratio of the other catalysts to the substrate is 1.5 to 2:1, preferably 1.5:1.
[0059] Furthermore, the molar amount of the sulfur reagent is 10–15 mol%.
[0060] Furthermore, the amount of the ligand used is 10–15 mol%.
[0061] Furthermore, the amount of the halogen catalyst used is 10–15 mol%.
[0062] Furthermore, the post-treatment refers to column chromatography separation after the reaction is complete. Furthermore, the column chromatography separation uses acetone elution.
[0063] Furthermore, R 1 Selected from C 1-20 Alkyl, -C(=O)-R 5 、-(CR 6 2) n -OC 6-20 Aryl-OC 6-20 Aryl, -(CR 6 2) n -C(=O)-OC 3-10 cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 .
[0064] Furthermore, R 1 Selected from C 1-10 Alkyl, -C(=O)-R 5 、-(CR 6 2) n -OC 6-12 Aryl-OC 6-12 Aryl, -(CR 6 2) n -C(=O)-OC 3-10 cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 62) n -C(=O)OR 5 .
[0065] Furthermore, R 3 Selected from hydrogen, C 1-10 Alkyl, -C(=O)-R 5 .
[0066] Furthermore, R 1 and R 3 The atoms bonded to them together form heterocycles with 5, 6, 7, 8, 9, or 10 ring atoms, preferably:
[0067] Furthermore, R 2 Selected from -C(=O)-R 5 -C(=O)OR 5 C 6-12 Aryl, -C(=O)-NH-R 5 .
[0068] Furthermore, R 6 Selected from hydrogen or C 1-20 alkyl.
[0069] Furthermore, Ar is selected from C 6-20 Aryl or C 1-20 Mixed aromatic compounds.
[0070] Furthermore, Ar is selected from Thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, pyridinyl, pyridinyl, triazinyl, tetraazinyl, indolyl, benzothiopheneyl, benzofuranyl, benzimidazolyl, inzolyl, benzotriazolyl, benzothiazolyl, benzothiadiazolyl, benzooxazolyl, isomerized quinolinyl, isomerized isoquinolinyl, phthalazinyl, quinoxolinyl, quinazolinyl, cinolinyl, or naphthinyl.
[0071] Furthermore, R 4 Selected from C 1-20 Haloalkyl, C 1-20 Alkyl, -C(=O)-R 5 、-(CR 6 2) n -OH, -(CR) 6 2) n -C(=O)-OH、-(CR 6 2) n -C(=O)-NH-R 5 、-(CR 6 2) n -NH-C(=O)-R 5-OC(=O)-R 5 、-(CR 6 2) n -OC 6-20 Aryl-OC 6-20 Aryl, -(CR 6 2) n -C(=O)-OC 3-10 cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS or -(CR) 6 2) n -C(=O)OR 5 ;
[0072] Or R 4 Forming with C atoms on Ar
[0073] Furthermore, the R 5 Selected from C 1-20 Alkyl, -CN, -OC 1-20 Alkyl, C 3-10 cycloalkyl, -NH-C 1-20 Alkyl, -C 6-20 Aryl-C 1-20 heteroaryl, -C 6-20 Aryl C 6-20 Aryl, C 6-20 Aryl or C 1-20 Mixed aromatic compounds.
[0074] Furthermore, the R 5 Selected from C 1-20 Alkyl, -CN, -OC 1-6 Alkyl, cyclohexyl, cyclopropyl, cyclopentyl, -NH-C 1-6 Alkyl, -phenyl-thiazolium, biphenyl, phenyl, naphthyl, furanyl, thiophene, pyrrolyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, pyridinyl, pyrazinyl, triazinyl, tetraazinyl, indolyl, benzothiophene, benzofuranyl, benzimidazolyl, inzolyl, benzotriazolyl, benzothiazolyl, benzothiazolyl, benzothiazolyl, benzooxazolyl, isomerized quinolinyl, isomerized isoquinolinyl, phthalazinyl, quinoxolinyl, quinazolinyl, cinolinyl, or naphthidyl.
[0075] Furthermore, the substituent R 7 Selected from hydrogen, deuterium, fluorine, chlorine, bromine, iodine, -CN, -OH, -C(=O)OH, -C(=O)-NH-C 1-20Alkyl group, -NH-C(=O)-C 1-20 Alkyl, C 1-20 Haloalkyl, C 1-20 Alkyl group, -C(=O)OC 1-20 Alkyl, -(CR) 6 2) n -C(=O)OH, -(CR) 6 2) n -C(=O)O·-C 1-20 Alkyl, -C(=O)-C 1-20 Alkyl group, -OC(=O)-C 1-20 Alkyl, -OC 1-20 Alkyl groups, -B (pin), -OTBS, -C (=O)OC 6-20 Aryl, -C(=O)-C 6-20 Aryl, -OC(=O)-C 6-20 Aryl, -OC 6-20 Aryl, -NHC(=O)-C 6-20 Aryl, C 6-20 Aryl, -C 6-20 Aryl-OC(=O)-C 1-20 Alkyl, -C 6-20 Aryl-C(=O)OC 1-20 Alkyl, -C 1-20 heteroaryl-C 6-20 aryl-S(=O)2-NH2,C 1-20 Heterocyclic group or C 1-20 Mixed aromatic compounds.
[0076] Furthermore, the substrate is selected from one of the following structures:
[0077]
[0078]
[0079]
[0080] The deuterated product is selected from one of the following structures:
[0081]
[0082]
[0083]
[0084] On the other hand, the present invention also provides a method for preparing ibuprofen deuterated compounds, which are obtained using the preparation method described in the present invention.
[0085] Beneficial effects
[0086] Compared with the prior art, the beneficial technical effects of the present invention are as follows:
[0087] 1. This invention provides a method for preparing deuterated compounds by photocatalysis and halogen atom catalysis, realizing the deuteration of aniline, amide N-α and benzylic compounds under photocatalytic conditions and halogen atom-mediated deuteration, with high deuteration rate, good selectivity, high product yield, and wide applicability.
[0088] 2. This invention employs a photocatalytic halogen atom as a HAT reagent to achieve approximately 90% deuteration at the benzylic or N-α position, with a recovery rate of 60-99%. From C(sp... 3 The )-H substrate undergoes direct deuteration reaction with high atom economy. Using halogen atoms as HAT reagents provides mild hydrogen abstraction and thus good selectivity. The deuteration rate is good, and it can directly achieve the deuteration of drug molecules such as ibuprofen.
[0089] Terminology Explanation
[0090] Unless otherwise stated, the following terms and phrases as used herein are intended to have the following meanings:
[0091] The term “and / or” should be understood to mean any one of the options or any combination of two or more of the options.
[0092] The terms “optional,” “optional,” or “optionally” refer to events or situations that may, but are not necessarily, occur as described below.
[0093] The term "alkyl" refers to a substituted or unsubstituted saturated hydrocarbon group, which can be straight-chain or branched. Specifically, it can be an alkyl group containing 1-20 carbon atoms, preferably a branched or unbranched saturated hydrocarbon group containing 1-16 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, etc. Furthermore, the alkyl group can also be substituted or unsubstituted. For example, the alkyl group can be substituted with one or more substituent groups.
[0094] In this invention, the alkyl halogroup is selected from -CH2Cl, -CHCl2, -CCl3, -CH2F, -CHF2, -CF3, CF3CH2-, CH3CF2-, CF3CF2- or CCl3CCl2-.
[0095] The term "aryl" refers to an aromatic group, typically derived from monocyclic or polycyclic aromatic hydrocarbons. Aryl groups can be unsubstituted or substituted with one or more substituents. Specific ranges of aryl groups include, but are not limited to, phenyl, naphthyl, biphenyl, anthryl, phenanthryl, etc. These aryl groups can be further substituted with the substituents described in this invention. For example, an aryl group can be phenyl, a phenyl substituted with methyl (tolyl), or a phenyl substituted with chlorine. The number of carbon atoms in an aryl group is typically 6-20 or 6-14, depending on the size and structure of the aromatic ring.
[0096] The term "cycloalkyl" refers to a non-aromatic carbonyl ring consisting of at least three carbon atoms, typically a saturated carbon ring. Specific examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Cycloalkyl groups can be monocyclic or bicyclic, such as bridged or spirocyclic rings. Furthermore, cycloalkyl groups can be unsubstituted or substituted with one or more substituents. The number of carbon atoms in cycloalkyl groups is typically between 3 and 8, for example, C60-C60. 3-8 Cycloalkyl.
[0097] The term "heterocyclic group" refers to a non-aromatic cyclic group comprising at least one carbon atom and at least one (e.g., 1-3) cyclic heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S). These heterocyclic groups can be monocyclic structures or bicyclic structures such as fused rings, bridged rings, or spirocyclic rings, and can be partially or fully saturated. For example, heterocyclic groups can be 3- to 10-membered saturated or unsaturated heterocyclic groups, and specific examples include tetrahydrofuranyl, pyrrolidinyl, oxoheterobutyl, azaheterobutyl, ethylene oxide, aziridinyl, thioheterobutyl, etc.
[0098] The term "heteroaryl" refers to a monocyclic or polycyclic aromatic ring structure containing at least one heteroatom (such as nitrogen, oxygen, or sulfur), which may contain 5 to 40 aromatic ring atoms, wherein at least one carbon atom is substituted by a heteroatom (such as nitrogen, oxygen, or sulfur). Heteroaryl can be a monocyclic structure or a polycyclic fused structure (such as naphthalene, anthracene, quinoline, etc.), and may be further substituted by the substituents described in this invention.
[0099] In this invention, the "substituent" is selected from one or more of hydrogen, deuterium, fluorine, chlorine, bromine, iodine, -CN, -OH, -C(=O)OH, -C(=O)-NH-alkyl, haloalkyl, alkyl, -C(=O)O-alkyl, -C(=O)-alkyl, -OC(=O)-alkyl, -O-alkyl, -OTBS, -C(=O)O-aryl, -C(=O)-aryl, -OC(=O)-aryl, -O-aryl, -NHC(=O)-aryl, aryl, heterocyclic, or heteroaryl. In this invention, the substituent may be further substituted. Detailed Implementation
[0100] The technical solution of the present invention will be illustrated below with examples. The scope of protection sought by the present invention includes, but is not limited to, the following embodiments.
[0101] Reaction mechanism:
[0102]
[0103] Photoexcited catalysts can activate CH bonds in substrates (compound I) to generate radical intermediates (compound II), thereby achieving a series of chemical transformations to obtain compound III.
[0104] Other substrates, such as Deuterated compounds were prepared in the same way, for example... Among them, R 1 R 2 R 3 R 4 R 6 Ar has the definition as described in this invention.
[0105] General Method A
[0106]
[0107] Among them, R 1 R 2 R 3 R 6 Having the definition as described in this invention; R 6’ It is an alkyl group.
[0108] N-α deuteration procedure details (GP-A): In a glove box, add Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1-4 mol%), NaBr (0.3 mmol, 1.5 equiv), S1 catalyst (10-15 mol%), compound of formula I (0.20 mmol, 1.0 equiv.), magnetic flux, and EtOAc (1.5-2.5 mL) in sequence to a 15 mL vial. Cap the vial with a diaphragm and secure it with electrical tape before removing it from the glove box. Add 150-200 μL of deuterium water outside the glove box. Then, coat the diaphragm cap with hot melt adhesive and allow it to cool and set. Stir in an oil bath at 60-80°C for approximately 1 minute, then turn on a 40 W blue lamp with a wavelength of 427 nm. React under these conditions for 48-72 hours. After the reaction was complete, the reaction liquid was filtered down using a short silica gel column with acetone as solvent. The solvent was then removed using a rotary evaporator, followed by column chromatography to obtain the pure reaction product. The yield was recorded by weighing, and the pure product was subjected to H₂ chromatography. 1 NMR analysis yielded the deuteration rate.
[0109] General Method B
[0110]
[0111] Detailed procedure for benzylic deuteration (GP-B): In a glove box, add Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1-4 mol%), NiBr2·DME (5-15 mol%), dtbbpy (10-15 mol%), S catalyst (10-15 mol%), compound of formula IV (0.20 mmol, 1.0 equiv.), magnetic flux, and i-PrOAc (1.5-2.5 mL) in sequence to a 15 mL vial. Cap the vial with a diaphragm cap, secure it with electrical tape, and remove it from the glove box. Add 150-200 μL of deuterium water outside the glove box. Then, coat the diaphragm cap with hot melt adhesive and allow it to cool and set. Stir in an oil bath at 60-80°C for approximately 1 minute, then turn on a 40W blue lamp at 427 nm. React under these conditions for 48-72 hours. After the reaction was complete, the reaction liquid was filtered down using a short silica gel column with acetone as solvent. The solvent was then removed using a rotary evaporator, followed by column chromatography to obtain the pure reaction product. The yield was recorded by weighing, and the pure product was then subjected to further processing. 1 H-NMR analysis yielded the deuteration rate.
[0112] Detailed procedure for benzylic deuteration (GP-C): In a glove box, add Ir[dF(CF3)ppy]2(dtbbpy)PF6 (1-4 mol%), NaBr (0.3 mmol, 1.5 equiv), S catalyst (10-15 mol%), compound IV (0.20 mmol, 1.0 equiv.), magnetic flux, and i-PrOAc (1.5-2.5 mL) in sequence to a 15 mL vial. Cap the vial with a diaphragm cap, secure it with electrical tape, and remove it from the glove box. Add 150-200 μL of deuterium water outside the glove box. Then, coat the diaphragm cap with hot melt adhesive and allow it to cool and set. Stir in an oil bath at 60-80°C for approximately 1 minute, then turn on a 40 W blue lamp at 427 nm. React under these conditions for 48-72 hours. After the reaction was complete, the reaction liquid was filtered down using a short silica gel column with acetone as solvent. The solvent was then removed using a rotary evaporator, followed by column chromatography to obtain the pure reaction product. The yield was recorded by weighing, and the pure product was then subjected to further processing. 1 H-NMR analysis yielded the deuteration rate.
[0113] Example 1
[0114]
[0115] The title compound, tert-butylpyrrololine-1-carboxylic acid ester-2,2,5,5-d4, was synthesized from tert-butylpyrrololine-1-carboxylic acid ester according to general method A. The product was purified by silica gel column chromatography (eluting with ethyl acetate / petroleum ether = 1:20). The product was a colorless oil.
[0116] 31.7 mg, 91% yield, 95% D
[0117] 1 H NMR (500MHz, CDCl3) (labeled) δ3.48-3.15 (m, 0.19H, 95%D), 1.80 (s, 4H), 1.45 (s, 9H).
[0118] 13 C NMR(126MHz, CDCl3)(labeled)δ154.9,79.0,46.1-45.0(m),28.7,25.7,24.9.
[0119] Example 2
[0120]
[0121] The title compound, tert-butylaziridine-1-carboxylate-2,2,7,7-d4, was synthesized from tert-butylaziridine-1-carboxylate according to general method A. The product was purified by silica gel column chromatography (eluting with ethyl acetate / petroleum ether = 1:50). The product was a colorless oil.
[0122] 41.2 mg, 97% yield, 93% D
[0123] 1 H NMR (500MHz, CDCl3) (labeled) δ3.33-3.21 (m, 0.28H, 93%D), 1.68-1.59 (m, 4H), 1.58-1.48 (m, 6H), 1.45 (s, 9H).
[0124] 13 C NMR(126MHz, CDCl3)(labeled)δ155.7,79.0,48.2-46.2(m,labeled),28.7,27.4,27.3,26.2,25.0.
[0125] Example 3
[0126]
[0127] The title compound, tert-butylaziridine-1-carboxylate-2,2,7,7-d4, was synthesized from tert-butylaziridine-1-carboxylate according to general method A. The product was purified by silica gel column chromatography (eluting with ethyl acetate / petroleum ether = 1:30). The product was a colorless oil.
[0128] 35.8 mg, 88% yield, 92% D
[0129] 1 H NMR(500MHz, CDCl3)(labeled)δ3.36-3.24(m,0.34H,92%D),1.68-1.58(m,4H),1.55-1.49(m,4H),1.44(s,9H).
[0130] 13 C NMR(126MHz, CDCl3)(labeled)δ155.9,79.0,47.3-45.4(m,labeled),28.7,28.4,28.3,27.5,26.9.
[0131] Example 4
[0132]
[0133] The title compound, tert-butylpiperidine-1-carboxylic acid ester-2,2,6,6-d4, was synthesized from tert-butylpiperidine-1-carboxylic acid ester according to general method A. The product was purified by silica gel column chromatography (eluting with ethyl acetate / petroleum ether = 1:30). The product was a colorless oil.
[0134] 33.4 mg, 88% yield, 93% D
[0135] 1 H NMR(500MHz, CDCl3)(labeled)δ3.34-3.24(m,0.30H,93%D),1.57-1.51(m,2H),1.50-1.44(m,4H),1.42(s,9H).
[0136] 13 C NMR(126MHz, CDCl3)(labeled)δ155.1,79.2,46.0-41.5(m,labeled),28.6,26.2-25.3(m),24.5.
[0137] Example 5
[0138]
[0139] The title compound, phenyl(pyrrololin-1-yl-2,2,5,5-d4) methyl ketone, was synthesized from phenyl(pyrrololin-1-yl) methyl ketone according to general method A. The product was purified by silica gel column chromatography (eluting with ethyl acetate / petroleum ether = 1:5). The product was a pale yellow oil.
[0140] 32.8 mg, 92% yield, 90% D
[0141] 1 H NMR(400MHz, CDCl3)(labeled)δ7.58-7.44(m,2H),7.43-7.32(m,3H),3.65-3.59( m,0.21H,90%D),3.42-3.36(m,0.21H,90%D),1.99-1.89(m,2H),1.87-1.78(m,2H).
[0142] 13 C NMR(126MHz, CDCl3)(labeled)δ169.9,137.4,129.9,128.4,127.2,50.0-48.4(m,labeled),46.4-45.3(m,labeled),26.6-26.1(m),24.6-24.2(m).
[0143] Example 6
[0144]
[0145] The title compound, N-(butyl-1,1-d2)benzamide, was synthesized from N-butylbenzamide according to general method A. The product was purified by preparative thin-layer chromatography (TLC) on silica gel with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a colorless oil.
[0146] 35.8 mg, 99% yield, 94% D
[0147] 1 H NMR(500MHz, CDCl3)(labeled)δ7.81-7.72(m,2H),7.51-7.45(m,1H),7.44-7.37(m,2H),6.26(s, 1H),3.46-3.38(m,0.12H,94%D),1.58(t,J=7.6Hz,2H),1.45-1.35(m,2H),0.94(t,J=7.4Hz,3H).
[0148] 13 C NMR(126MHz, CDCl3)(labeled)δ167.7,135.0,131.4,128.6,127.0,39.8-38.9(m,labeled),32.2-31.1(m),20.2,13.9.
[0149] Example 7
[0150]
[0151] The title compound N-(butyl-1,1-d2)-4-methoxybenzamide was synthesized from N-butyl-4-methoxybenzamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0152] 42.3 mg, 99% yield, 94% D
[0153] 1 H NMR(500MHz, CDCl3)(labeled)δ7.75-7.66(m,2H),6.91-6.84(m,2H),6.26(s,1H),3.81(s,3 H),3.43-3.34(m,0.11H,94%D),1.60-1.51(m,2H),1.42-1.32(m,2H),0.92(t,J=7.3Hz,3H).
[0154] 13 C NMR(126MHz, CDCl3)(labeled)δ167.3,162.1,128.8,127.3,113.8,55.5,39.7-38.9(m,labeled),31.9-31.5(m),20.2,13.9.
[0155] Example 8
[0156]
[0157] The title compound, methyl 4-((butyl-1,1-d2)carbamoyl)benzoate, was synthesized from methyl 4-(butylcarbamoyl)benzoate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0158] 38.4 mg, 81% yield, 86% D
[0159] 1 H NMR(400MHz, CDCl3)(labeled)δ8.15-7.90(m,2H),7.89-7.65(m,2H),6.56(s,1H),3.90(s,3 H),3.47-3.31(m,0.29H,86%D),1.63-1.48(m,2H),1.44-1.29(m,2H),0.91(t,J=7.3Hz,3H).
[0160] 13 C NMR(101MHz, CDCl3)(labeled)δ166.9,166.5,138.9,132.6,129.8,127.1,52.5,40.5-39.0(m,labeled),31.9-31.3(m),20.2,13.9.
[0161] Example 9
[0162]
[0163] The title compound, 4-(tert-butyl)-N-(propyl-1,1-d2)benzamide, was synthesized from 4-(tert-butyl)-N-propylbenzamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:10. The product was a white solid.
[0164] 41.1 mg, 93% yield, 92% D
[0165] 1H NMR(400MHz, CDCl3)(labeled)δ7.74-7.67(m,2H),7.47-7.39(m,2H),6.26(s,1H),3 .43-3.34(m,0.16H,92%D),1.61(q,J=7.3Hz,2H),1.32(s,9H),0.96(t,J=7.4Hz,3H).
[0166] 13 C NMR(101MHz, CDCl3)(labeled)δ167.7,154.9,132.2,126.8,125.6,41.83-40.64(m,labeled),35.0,31.3,23.1-22.9(m),11.5.
[0167] Example 10
[0168]
[0169] The title compound, 4-methoxyphenyl(pyrrololin-1-yl-2,2,5,5-d4) methyl ketone, was synthesized from 4-methoxyphenyl(pyrrololin-1-yl) methyl ketone according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:1 ratio. The product was a white solid.
[0170] 37.4 mg, 90% yield, 92% D
[0171] 1 H NMR(400MHz, CDCl3)(labeled)δ7.55-7.47(m,2H),6.92-6.84(m,2H),3.82(s,3H),3.63-3.38(m,0.34H,92%D),1.96-1.82(m,4H).
[0172] 13 C NMR(101MHz, CDCl3)(labeled)δ169.6,160.9,129.5,129.3,113.5,55.4,50.2-48.6(m,labeled),46.7-45.0(m,labeled),26.6-26.2(m),24.6-24.1(m).
[0173] Example 11
[0174]
[0175] The title compound, methyl 4-(pyrrololin-1-carbonyl-2,2,5,5-d4)benzoate, was synthesized from methyl 4-(pyrrololin-1-carbonyl)benzoate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:1 ratio. The product was a white solid.
[0176] 40.9 mg, 87% yield, 85% D
[0177] 1 H NMR(400MHz, CDCl3)(labeled)δ8.04(d,J=8.3Hz,2H),7.54(d,J=8.2Hz,2H),3.90(s,3H),3.6 5-3.56(m,0.30H,85%D),3.38-3.29(m,0.30H,85%D),1.92(t,J=6.5Hz,2H),1.89-1.77(m,2H).
[0178] 13 C NMR(101MHz,CDCl3)(labeled)δ168.8,166.5,141.5,131.2,129.7,127.1,52.4,49 .63-48.66(m,labeled),46.39-45.57(m,labeled),26.6-26.0(m),24.7-24.1(m).
[0179] Example 12
[0180]
[0181] The title compound, N-(6-((tert-butyldimethylsiloxy)oxy)hexyl-1,1-d2)benzamide, was synthesized from N-(6-((tert-butyldimethylsiloxy)oxy)hexyl)benzamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:10. The product was a colorless oily liquid.
[0182] 57.0 mg, 85% yield, 91% D
[0183] 1H NMR(400MHz, CDCl3)(labeled)δ7.78-7.72(m,2H),7.49-7.42(m,1H),7.41-7.35(m,2H),6.40(s,1H),3.61-3.53(m,0.46 H,77%D),3.43-3.34(m,0.19H,91%D),1.63-1.53(m,2H),1.54-1.45(m,2H),1.40-1.31(m,4H),0.88(s,9H),0.02(s,6H).
[0184] 13 C NMR(101MHz,CDCl3)(labeled)δ167.7,135.0,131.4,128.6,127.0,63.7-61.8(m,labeled),4 0.6-38.7(m,labeled),33.0-32.4(m),29.9-29.4(m),26.9,26.1,25.7-25.6(m),18.5,-5.1.
[0185] Example 13
[0186]
[0187] The title compound, methyl 7-benzamidoheptanate-7,7-d2, was synthesized from methyl 7-benzamidoheptanate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent (1:5). The product was a white solid.
[0188] 51.5 mg, 93% yield, 91% D
[0189] 1 H NMR(400MHz, CDCl3)(labeled)δ7.78-7.71(m,2H),7.48-7.40(m,1H),7.40-7.33(m,2H),6.50(s,1H), 3.62(s,3H),3.41-3.30(m,0.18H,91%D),2.27(t,J=7.5Hz,2H),1.65-1.52(m,4H),1.38-1.26(m,4H).
[0190] 13C NMR(101MHz, CDCl3)(labeled)δ174.3,167.7,134.9,131.3,128.6,127.0,51.5,40.1-38.8(m,labeled),34.0,29.7-29.0(m),28.8,26.6,24.9.
[0191] Example 14
[0192]
[0193] The title compound, phenyl(pyrrololin-1-yl-2,2,5,5-d4) methyl ketone, was synthesized from phenylpyrrololin-1-carboxylic acid ester according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:10. The product was a white solid.
[0194] 30.4 mg, 78% yield, 91% D
[0195] 1 H NMR(400MHz, CDCl3)(labeled)δ7.41-7.28(m,2H),7.23-7.06(m,3H),3.59-3.42(m,0.36H,91%D),2.03-1.81(m,4H).
[0196] 13 C NMR(101MHz, CDCl3)(labeled)δ153.4,151.6,129.3,125.2,121.9,46.7-45.3(m,labeled),25.9-25.6(m),25.3-24.6(m).
[0197] Example 15
[0198]
[0199] Ethyl 6-benzamidohexanoate-6,6-d2, the title compound, was synthesized from ethyl 6-benzamidohexanoate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a colorless, oily liquid.
[0200] 50.2 mg, 95% yield, 94% D
[0201] 1H NMR(400MHz, CDCl3)(labeled)δ7.78-7.72(m,2H),7.50-7.43(m,1H),7.42-7.35(m,2H),6.36(s,1H), 4.03(t,J=6.6Hz,2H),3.44-3.36(m,0.13H,94%D),2.02(s,3H),1.67-1.55(m,4H),1.44-1.33(m,4H).
[0202] 13 C NMR(101MHz, CDCl3)(labeled)δ171.3,167.7,134.9,131.4,128.6,127.0,64.5,40.3-38.7(m,labeled),29.4,28.6,26.6,25.7,21.1.
[0203] Example 16
[0204]
[0205] The title compound, 2,2-dimethyl-1-(pyrrolin-1-yl-2,2,5,5-d4)propane-1-one, was synthesized from 2,2-dimethyl-1-(pyrrolin-1-yl)propane-1-one according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:5 ratio. The product was a pale yellow solid.
[0206] 23.1 mg, 74% yield, 95% D.
[0207] H NMR (400MHz, CDCl3) (labeled) δ3.58-3.43 (m, 0.21H, 95%D), 1.92-1.69 (m, 4H), 1.24 (s, 9H).
[0208] 13 C NMR(101MHz, CDCl3)(labeled)δ176.7,47.6(m,labeled),39.1,27.7,23.0.
[0209] Example 17
[0210]
[0211] The title compound, N-(tert-butyl)pyrrololine-2,2,5,5-d4-1-carboxamide, was synthesized from N-(tert-butyl)pyrrololine-1-carboxamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:4 ratio. The product was a white solid.
[0212] 30.2 mg, 88% yield, 94% D
[0213] 1 H NMR(400MHz, CDCl3)(labeled)δ4.00(s,1H),3.28-3.19(m,0.25H,94%D),1.91-1.77(m,4H),1.33(s,9H).
[0214] 13 C NMR(101MHz, CDCl3)(labeled)δ156.5,50.7,45.6-44.4(m,labeled),29.8,25.8-25.3(m).
[0215] Example 18
[0216]
[0217] The title compound, 6-benzamidohexyl-6,6-d2-benzoate, was synthesized from 6-benzamidohexylbenzoate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0218] 60.3 mg, 92% yield, 92% D
[0219] 1 H NMR(400MHz, CDCl3)(labeled)δ8.03(d,J=7.6Hz,2H),7.76(d,J=7.4Hz,2H),7.63-7.33(m,6H),6.3 2(s,1H),4.4-4.2(m,2H),3.49-3.35(m,0.16H,92%D),1.85-1.74(m,2H),1.63(m,2H),1.47(m,4H).
[0220] 13 C NMR(101MHz, CDCl3)(labeled)δ167.7,166.9,135.0,133.0,131.5,130.6,129.7,128.7,128.5,127.0,65.0,39.5-39.1(m,labeled),29.6,28.8,26.7,25.9.
[0221] Example 19
[0222]
[0223] The title compound, N-(5-cyanopentyl-1,1-d2)benzamide, was synthesized from N-(5-cyanopentyl)benzamide according to general method A. The product was purified by preparative thin-layer chromatography (TLC) on silica gel, with ethyl acetate / petroleum ether as eluent in a 1:1 ratio. The product was a white solid.
[0224] 40.3 mg, 92% yield, 86% D
[0225] 1 H NMR(400MHz, CDCl3)(labeled)δ7.75(d,J=7.5Hz,2H),7.5-7.4(m,1H),7.4-7.3(m,2H),6.56(s ,1H),3.45-3.33(m,0.28H,86%D),2.31(t,J=7.0Hz,2H),1.75-1.56(m,4H),1.55-1.42(m,2H).
[0226] 13 C NMR (101MHz, CDCl3) δ167.8,134.7,131.5,128.6,127.0,119.7,39.7-38.6(m,labeled),29.0-28.6(m),26.0,25.1,17.1.
[0227] Example 20
[0228]
[0229] The title compound, tert-butyl-4-phenylpiperazine-1-carboxylate-3,3,5,5-d4, was synthesized from tert-butyl-4-phenylpiperazine-1-carboxylate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:5 ratio. The product was a white solid.
[0230] 47.9 mg, 91% yield, 96% D
[0231] 1 H NMR(400MHz, CDCl3)(labeled)δ7.34-7.23(m,2H),6.97-6.83(m,3H),3.66-3.46(m,4H),3.14-3.04(m,0.18H,96%D),1.48(s,9H).
[0232] 13C NMR(101MHz, CDCl3)(labeled)δ154.9,151.4,129.3,120.3,116.7,80.0,49.5-46.6(m,labeled),45.3-42.0(m,labeled),28.6.
[0233] Example 21
[0234]
[0235] The title compound, N-(6-(5-chloro-2-(2,4-dichlorophenoxy)phenoxy)hexyl-1,1-d2)benzamide, was synthesized from N-(6-(5-chloro-2-(2,4-dichlorophenoxy)phenoxy)hexyl)benzamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0236] 81.7 mg, 83% yield, 85% D
[0237] 1 H NMR(400MHz, CDCl3)(labeled)δ7.75(d,J=7.5Hz,2H),7.55-7.46(m,1H),7.46-7.36(m,3H),7.14-7.03(m,1H),7.02-6.87(m,3H),6.61(d,J=8.9H z,1H),6.16(s,1H),3.89(t,J=6.2Hz,2H),3.44-3.34(m,0.31H,85%D),1. 66-1.57(m,2H),1.57-1.48(m,2H),1.36-1.27(m,2H),1.25-1.16(m,2H).
[0238] 13 C NMR(101MHz, CDCl3)(labeled)δ167.7,152.8,151.1,142.8,134.9,131.4,130.8,130.1,128.6,127.6,1 27.0,124.2,122.4,121.0,117.7,114.7,68.9,40.1-39.1(m,labeled),29.6-29.4(m),28.9,26.5,25.6.
[0239] Example 22
[0240]
[0241] The title compound, 1-(pyrrolin-1-yl-2,2,5,5-d4)octadecane-1-one, was synthesized from 1-(pyrrolin-1-yl)octadecane-1-one according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0242] 61.2 mg, 90% yield, 94% D
[0243] 1 H NMR(400MHz, CDCl3)(labeled)δ3.41(t,J=6.8Hz,0.12H,94%D),3.36(t,J=6.8Hz,0.12H,94%D),2.23-2.18 (m,2H),1.95-1.85(m,2H),1.85-1.75(m,2H),1.68-1.53(m,2H),1.33-1.18(m,28H),0.84(t,J=6.7Hz,3H).
[0244] 13 C NMR(101MHz, CDCl3)(labeled)δ172.0,46.5-45.8(m,labeled),45.4-44.7(m,labeled) 35.0,32.0,29.8,29.8,29.7,29.6,29.6,29.5,26.1,26.0,25.1,24.4,24.3,22.8,14.2.
[0245] Example 23
[0246]
[0247] The title compound, 1-phenylpyrrolin-2-one-5,5-d2, was synthesized from 1-phenylpyrrolin-2-one according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:1 ratio. The product was a white solid.
[0248] 29.3 mg, 90% yield, 91% D
[0249] 1 H NMR(400MHz, CDCl3)(labeled)δ7.67-7.55(m,2H),7.42-7.31(m,2H),7.19-7.0 9(m,1H),3.87-3.80(m,0.18H,91%D),2.60(t,J=8.1Hz,2H),2.22-2.08(m,2H).
[0250] 13C NMR(101MHz, CDCl3)(labeled)δ174.4,139.6,128.9,124.6,120.1,49.8-46.9(m,labeled),32.9,18.1-17.8(m).
[0251] Example 24
[0252]
[0253] The title compound, tert-butyl(3-methylbutyl-1,1,3-d3)carbamate, was synthesized from tert-butylisopentylcarbamate according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a colorless liquid.
[0254] 27.8 mg, 74% yield, 95% D
[0255] 1 H NMR(400MHz, CDCl3)(labeled)δ4.46(s,1H),3.16-3.02(m,0.10H,95%D),1.68- 1.52(m,0.70H,30%D),1.43(s,9H),1.34(d,J=6.3Hz,2H),0.89(d,J=6.5Hz,6H).
[0256] 13 C NMR(101MHz, CDCl3)(labeled)δ156.2,79.1,39.1-38.7(m,labeled),28.6,25.9,22.6,22.5.
[0257] Example 25
[0258]
[0259] The title compound, 1,3-bis(butyl-1,1-d2)urea, was synthesized from 1,3-dibutylurea according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:1 ratio. The product was a white solid.
[0260] 34.0 mg, 97% yield, 93% D
[0261] 1 H NMR (400MHz, CDCl3) (labeled) δ5.05 (s, 2H), 3.16-3.05 (m, 0.27H, 93%D), 1.50-1.38 (m, 4H), 1.38-1.22 (m, 4H), 0.89 (t, J = 7.3Hz, 6H).
[0262] 13 C NMR(101MHz, CDCl3)(labeled)δ159.2,40.3-39.1(m,labeled),32.5-32.4(m),20.2,14.0.
[0263] Example 26
[0264]
[0265] The title compound, N-(butyl-1,1-d2)thiophene-2-carboxamide, was synthesized from N-butylthiophene-2-carboxamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0266] 35.1 mg, 95% yield, 89% D
[0267] 1 H NMR(400MHz, CDCl3)(labeled)δ7.51(dd,J=3.7,1.2Hz,1H),7.43(dd,J=5.0,1.2Hz,1H),7.04(dd,J=5.0,3.7 Hz,1H),6.24(s,1H),3.43-3.35(m,0.22H,89%D),1.60-1.52(m,2H),1.43-1.33(m,2H),0.93(t,J=7.3Hz,3H).
[0268] 13 C NMR(101MHz, CDCl3)(labeled)δ162.1,139.4,129.8,128.0,127.7,39.9-39.0(m,labeled),31.9-31.6(m),20.2,13.9.
[0269] Example 27
[0270]
[0271] The title compound, N-(heptane-2-yl-2-d)benzamide, was synthesized from N-(heptane-2-yl)benzamide according to general method A. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:10. The product was a white solid.
[0272] 40.6 mg, 92% yield, 84% D
[0273] 1H NMR(400MHz, CDCl3)(labeled)δ7.81-7.69(m,2H),7.50-7.43(m,1H),7.43-7.35(m,2H),6.04(s,1H),4 .24-4.11(m,0.16H,84%D),1.58-1.45(m,2H),1.40-1.24(m,6H),1.23-1.18(m,3H),0.92-0.82(m,3H).
[0274] 13 C NMR(101MHz, CDCl3)(labeled)δ167.0,135.2,131.3,128.6,127.0,46.1-45.1(m,labeled),37.2-36.9(m),31.8,25.9,22.7,21.2-20.9(m),14.1.
[0275] Example 28
[0276]
[0277] The title compound 4-(pentyl-1,1-d2)-1,1'-biphenyl was synthesized from 4-pentyl-1,1'-biphenyl according to general method B. The product was purified by silica gel column chromatography using petroleum ether as the eluent. The product was a colorless liquid.
[0278] 37.5 mg, 83% yield, 91% D
[0279] 1 H NMR(400MHz, CDCl3)(labeled)δ7.69-7.59(m,2H),7.54(d,J=7.9Hz,2H),7.48-7.41(m,2H),7.38-7.32(m,1H ),7.28(d,J=7.9Hz,2H),2.71-2.62(m,0.18H,91%D),1.77-1.59(m,2H),1.45-1.33(m,4H),0.98-0.89(m,3H).
[0280] 13 C NMR(101MHz, CDCl3)(labeled)δ142.2,141.4,138.7,129.0,128.9,127.2,127.1,35.5-34.9(m,labeled),31.7,31.4-30.9(m),22.8,14.2.
[0281] Example 29
[0282]
[0283] The title compound 6-(ethyl-1,1-d2)-2-phenylbenzothiazole was synthesized from 6-ethyl-2-phenylbenzothiazole according to general method C. The product was purified by preparative thin-layer chromatography (TLC) on silica gel with ethyl acetate / petroleum ether at a ratio of 1:20. The product was a white solid.
[0284] 31.4 mg, 65% yield, 89% D
[0285] 1 H NMR(400MHz, CDCl3)(labeled)δ8.15-8.04(m,2H),7.99(d,J=8.4Hz,1H),7.71(d,J=1.8Hz,1 H),7.52-7.46(m,3H),7.34(dd,J=8.4,1.8Hz,1H),2.78(m,0.23H,89%D),1.35-1.25(m,3H).
[0286] 13 C NMR(101MHz, CDCl3)(labeled)δ167.3,152.6,141.9,135.4,133.9,130.9,129.1,127.6,127.0,123.0,120.3,29.2-28.1(m,labeled),15.9-15.8(m).
[0287] Example 31
[0288]
[0289] The title compound 4-(propyl-1,1-d2)-1,1'-biphenyl was synthesized from 4-propyl-1,1'-biphenyl according to general method B. The product was purified by silica gel column chromatography using petroleum ether as the eluent. The product was a colorless liquid.
[0290] 33.0 mg, 83% yield, 91% D
[0291] 1 H NMR(400MHz, CDCl3)(labeled)δ7.65-7.60(m,2H),7.58-7.53(m,2H),7.49-7.43(m,2H),7.38-7.33 (m,1H),7.31-7.27(m,2H),2.70-2.62(m,0.18H,91%D),1.71(q,J=7.3Hz,2H),1.02(t,J=7.3Hz,3H).
[0292] 13 C NMR(101MHz, CDCl3)(labeled)δ142.0,141.4,138.8,129.1,128.9,127.2,127.1,127.1,39.7-35.6(m,labeled),27.4-20.4(m),14.0.
[0293] Example 32
[0294]
[0295] The title compound, 1-(6-(tert-butyl)-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl-3,3-d2)ethane-1-one, was synthesized from 1-(6-(tert-butyl)-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethane-1-one according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent (1:20). The product was a white solid.
[0296] 36.9 mg, 75% yield, 90% D
[0297] 1 H NMR(400MHz, CDCl3)(labeled)δ7.73-7.69(m,1H),7.37-7.34(m,1H),3.20-3.14 (m,0.21H,90%D),2.63-2.57(m,3H),1.96-1.89(m,2H),1.37(s,9H),1.27(s,6H).
[0298] 13 C NMR(101MHz, CDCl3)(labeled)δ200.4,154.6,150.1,141.1,133.9,124.7,123.5,43.6,41.6-41.1(m),34.9,31.7,31.0-30.1(m,labeled),29.0,28.7.
[0299] Example 33
[0300]
[0301] The title compound, 4-phenylbutyl-4,4-d2-benzoate, was synthesized from 4-phenylbutylbenzoate according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a colorless liquid.
[0302] 35.0 mg, 68% yield, 91% D
[0303] 1 H NMR(400MHz, CDCl3)(labeled)δ8.11-8.04(m,2H),7.62-7.55(m,1H),7.50-7.44(m,2H),7.38-7. 30(m,2H),7.27-7.19(m,3H),4.38(t,J=6.0Hz,2H),2.77-2.68(m,0.19H,91%),1.94-1.75(m,4H).
[0304] 13 C NMR(101MHz, CDCl3)(labeled)δ166.8,142.1,133.0,130.6,129.7,128.6,128.5,128.5,126.0,65.0,35.8-34.6(m,labeled),28.4,28.1-27.5(m).
[0305] Example 34
[0306]
[0307] The title compound 4-(ethyl-1,1-d2)-1,1'-biphenyl was synthesized from 4-ethyl-1,1'-biphenyl according to general method B. The product was purified by preparative thin-layer chromatography (TLC) on silica gel, with petroleum ether as the eluent. The product was a colorless solid.
[0308] 34.8 mg, 95% yield, 92% D
[0309] 1 H NMR(400MHz, CDCl3)(labeled)δ7.67-7.59(m,2H),7.60-7.53(m,2H),7.50-7.43(m,2H),7.39-7 .33(m,1H),7.35-7.27(m,2H),2.72(qt,J=7.6,2.2Hz,0.16H,92%D),1.35-1.26(m,2.90H,3%D).
[0310] 13 C NMR(101MHz, CDCl3)(labeled)δ143.5,141.4,138.8,128.9,128.5,127.3,127.2,127.1,28.1(m,labeled),15.7-15.5(m).
[0311] Example 35
[0312]
[0313] The title compound, 4-phenylbutyl-4,4-d2-acetic acid ester, was synthesized from 4-phenylbutylacetic acid ester according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a colorless liquid.
[0314] 31.4 mg, 81% yield, 90% D
[0315] 1 H NMR(400MHz, CDCl3)(labeled)δ7.32-7.26(m,2H),7.22-7.16(m,3H),4.13-4.04(m,2H),2.68-2.60(m,0.20H,90%D),2.05(s,3H),1.72-1.63(m,4H).
[0316] 13 C NMR(101MHz, CDCl3)(labeled)δ171.3,142.1,128.5,128.5,126.0,64.5,35.9-34.3(m,labeled),28.3,28.0-27.5(m),21.1.
[0317] Example 36
[0318]
[0319] The title compound, N-(4-(ethyl-1,1-d2)phenyl)tert-butylamide, was synthesized from N-(4-ethylphenyl)tert-butylamide according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a white solid.
[0320] 31.9 mg, 77% yield, 88% D
[0321] 1 H NMR(400MHz, CDCl3)(labeled)δ7.46-7.39(m,2H),7.28(s,1H),7.18-7.10(m,2H),2.65-2.54(m,0.25H,88%D),1.31(s,9H),1.24-1.15(m,3H).
[0322] 13 C NMR(101MHz, CDCl3)(labeled)δ176.6,140.4,135.8,128.4,120.3,39.7,27.8,16.2-15.4(m).
[0323] Example 37
[0324]
[0325] The title compound, hexyl-1,1-d2-benzene, was synthesized from hexylbenzene according to general method B. The product was purified by silica gel column chromatography using petroleum ether as the eluent. The product was a colorless liquid.
[0326] 27.7 mg, 84% yield, 87% D
[0327] 1 H NMR(400MHz, CDCl3)(labeled)δ7.33-7.27(m,2H),7.24-7.16(m,3H),2.65-2 .57(m,0.26H,87%D),1.67-1.59(m,2H),1.39-1.30(m,6H),0.95-0.88(m,3H).
[0328] 13 C NMR(101MHz, CDCl3)(labeled)δ143.1,128.6,128.4,125.7,36.1-35.1(m,labeled),31.9,31.7-31.4(m),29.2,22.8,14.3.
[0329] Example 38
[0330]
[0331] The title compound 1-(ethyl-1,1-d2)-2-methoxybenzene was synthesized from 1-ethyl-2-methoxybenzene according to general method B. The product was purified by silica gel column chromatography using petroleum ether as the eluent. The product was a colorless liquid.
[0332] 21.5 mg, 78% yield, 92% D
[0333] 1 H NMR(400MHz, CDCl3)(labeled)δ7.22-7.13(m,2H),6.93-6.88(m,1H),6.85(d,J=8.1Hz,1H),3.84(s,3H),2.69-2.58(m,0.17H,92%D),1.23-1.16(m,3H).
[0334] 13C NMR(101MHz, CDCl3)(labeled)δ157.6,132.7,129.1,126.9,120.6,110.3,55.4,24.0-21.9(m,labeled),14.7-13.6(m).
[0335] Example 39
[0336]
[0337] The title compound, 4-phenylbutane-1,1,4,4-d4-1-ol, was synthesized from 4-phenylbutanol according to general method B. The product was purified by preparative thin-layer chromatography (TLC) on silica gel, with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a colorless liquid.
[0338] 20.7 mg, 68% yield, 88% D
[0339] 1 H NMR(400MHz, CDCl3)(labeled)δ7.42-7.36(m,2H),7.34-7.27(m,3H),3.81-3.68( m,1.61H,20%D),2.80-2.71(m,0.23H,88%D),1.86-1.76(m,2H),1.77-1.67(m,2H).
[0340] 13 C NMR(101MHz, CDCl3)(labeled)δ142.4,128.6,128.5,125.9,63.4-62.1(m,labeled),36.2-34.6(m,labeled),33.0-32.0(m),28.1-26.5(m).
[0341] Example 40
[0342]
[0343] The title compound 1-(ethyl-1,1-d2)-4-methoxybenzene was synthesized from 1-ethyl-4-methoxybenzene according to general method B. The product was purified by silica gel column chromatography using petroleum ether as the eluent. The product was a colorless liquid.
[0344] 23.4 mg, 85% yield, 90% D
[0345] 1H NMR(400MHz, CDCl3)(labeled)δ7.16-7.10(m,2H),6.87-6.82(m,2H),3.80(s,3H),2.63-2.54(m,0.20H,90%D),1.25-1.17(m,3H).
[0346] 13 C NMR(101MHz, CDCl3)(labeled)δ157.8,136.5,128.9,113.9,55.4,28.5-27.0(m,labeled),17.3-15.2(m).
[0347] Example 41
[0348]
[0349] The title compound, 4-(ethyl-1,1-d2)phenylacetate, was synthesized from 4-ethylphenylacetate according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a colorless liquid.
[0350] 21.9 mg, 66% yield, 90% D
[0351] 1 H NMR(400MHz, CDCl3)(labeled)δ7.23-7.17(m,2H),7.03-6.96(m,2H),2.69-2.58(m,0.21H,90%D),2.29(s,3H),1.27-1.18(m,3H).
[0352] 13 C NMR(101MHz, CDCl3)(labeled)δ169.9,148.8,141.9,128.9,121.4,28.7-27.0(m,labeled),21.3,16.0-15.0(m).
[0353] Example 42
[0354]
[0355] The title compound 1-(butyl-1,1-d2)-4-chlorobenzene was synthesized from 1-butyl-4-chlorobenzene according to general method B. The product was purified by silica gel column chromatography using petroleum ether as the eluent. The product was a colorless liquid.
[0356] 22.4 mg, 66% yield, 83% D
[0357] 1 H NMR(400MHz, CDCl3)(labeled)δ7.24(d,J=8.0Hz,2H),7.11(d,J=8.1Hz,2H),2.61- 2.52(m,0.35H,83%D),1.60-1.53(m,2H),1.40-1.29(m,2H),0.93(t,J=7.3Hz,3H).
[0358] 13 C NMR(101MHz, CDCl3)(labeled)δ141.4,131.4,129.9,128.5,35.1-34.1(m,labeled),33.8-33.4(m),22.4-22.3(m),14.1.
[0359] Example 43
[0360]
[0361] The title compound, N-(4-phenylbutyl-1,1,4,4-d4)benzamide, was synthesized from N-(4-phenylbutyl)benzamide according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0362] 34.9 mg, 73% yield. 87% benzyl deuteration, 50% N-α deuteration.
[0363] 1 H NMR(400MHz, CDCl3)(labeled)δ7.81-7.72(m,2H),7.53-7.47(m,1H),7.46-7.40(m,2H),7.32-7.27(m,2H ),7.25-7.17(m,3H),6.22(s,1H),3.56-3.40(m,1H,50%D),2.71-2.62(m,0.27H,87%D),1.76-1.61(m,4H).
[0364] 13 C NMR(101MHz,CDCl3)(labeled)δ167.7,142.2,134.9,131.5,128.7,128.6,128.5,127.0 ,126.0,40.3-39.3(m,labeled),35.5-34.7(m,labeled),29.6-29.0(m),28.8-28.5(m).
[0365] Example 44
[0366]
[0367] The title compound, 5-phenylvaleric acid-5,5-d2, was synthesized from 5-phenylvaleric acid according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a white solid.
[0368] 30.4 mg, 84% yield, 88% D
[0369] 1 H NMR(400MHz, CDCl3)(labeled)δ7.31-7.24(m,2H),7.21-7.13(m,3H),2.66-2.57(m,0.24H,88%D),2.42-2.32(m,2H),1.71-1.63(m,4H).
[0370] 13 C NMR(101MHz, CDCl3)(labeled)δ180.0,142.1,128.6,128.5,126.0,35.8-34.7(m,labeled),34.1,31.0-30.6(m),24.4.
[0371] Example 45
[0372]
[0373] The title compound, methyl 2-(4-(2-methylpropyl-1,1-d2)phenyl)propionate-2-d, was synthesized from methyl 2-(4-isobutylphenyl)propionate according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a colorless liquid.
[0374] 42.5 mg, 95% yield, 91% D, 30% D at position 2
[0375] 1 H NMR(400MHz, CDCl3)(labeled)δ7.23-7.18(m,2H),7.13-7.08(m,2H),3.71(q,J=7.2Hz,0.70H,30%D), 3.66(s,3H),2.47-2.41(m,0.19H,91%D),1.90-1.78(m,1H),1.52-1.47(m,3H),0.91(d,J=6.6Hz,6H).
[0376] 13C NMR(101MHz, CDCl3)(labeled)δ175.4,140.7,137.9,129.5,127.3,52.1,45.2,45.1-43.9(m,labeled),30.3-30.1(m),22.5,18.9-18.6(m).
[0377] Example 46
[0378]
[0379] The title compound, methyl 4-chloro-3-(ethyl-1,1-d2)-1-methyl-1H-pyrazole-5-carboxylic acid ester, was synthesized from methyl 4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxylic acid ester according to general method B. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:5 ratio. The product was a white solid.
[0380] 31.7 mg, 78% yield, 72% D
[0381] 1 H NMR(400MHz, CDCl3)(labeled)δ4.07(s,3H),3.91(s,3H),2.66-2.56(m,0.56H,72%D),1.25-1.17(m,3H).
[0382] 13 C NMR(101MHz, CDCl3)(labeled)δ159.8,150.5,129.0,113.3,52.2,40.8,19.7-18.5(m,labeled),13.0-12.5(m).
[0383] Example 47
[0384]
[0385] The title compound, methyl 4-(ethyl-1,1-d2)benzoate, was synthesized from methyl 4-ethylbenzoate according to Universal Method B. The product obtained after the initial reaction was used as a substrate for further reactions and reintroduced into Universal Method B for a second reaction cycle. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent at a ratio of 1:20. The product was a white solid.
[0386] 1H NMR(400MHz, CDCl3)(labeled)δ7.99-7.92(m,2H),7.29-7.23(m,2H),3.90(s,3H),2.74-2.63(m,0.28H,86%D),1.31-1.21(m,3H).
[0387] 13 C NMR(101MHz, CDCl3)(labeled)δ167.4,149.9,129.9,128.1,127.8,52.1,29.1-28.1(m,labeled),15.5-15.0(m).
[0388] Example 48
[0389]
[0390] The title compound, 2-(4-(2-methylpropyl-1,1-d2)phenyl)propionic acid-2-d, was synthesized from 2-(4-isobutylphenyl)propionic acid according to general method C. The product was purified by silica gel column chromatography with ethyl acetate / petroleum ether as eluent in a 1:3 ratio. The product was a pale yellow solid.
[0391] 34.5 mg, 83% yield.
[0392] 1 H NMR(400MHz, CDCl3)(labeled)δ7.23(d,J=7.8Hz,2H),7.11(d,J=7.9Hz,2H),3.72(q,J=7.3Hz,0 .61H, 39%D), 2.44 (m, 0.24H, 88%D), 1.93-1.78 (m, 1H), 1.55-1.46 (m, 3H), 0.91 (d, J = 6.6Hz, 6H).
[0393] 13 C NMR(101MHz, CDCl3)(labeled)δ181.2,141.0,137.2,129.6,127.5,45.6-44.2(m,labeled),30.2,30.5-29.2(m,labeled),22.5,18.3.
[0394] The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.
Claims
1. A method for preparing deuterated compounds by photocatalysis and halogen atom catalysis, characterized in that, Includes the following steps: Step S1: Add the photocatalyst, other catalysts, sulfur reagent, substrate, and solvent to a reactor equipped with magnetic particles; Step S2: After adding the deuterium source, seal the reactor; Step S3: Start stirring, heat the reactants to the reaction temperature, and react under light until the reaction is complete. After post-processing, obtain the deuterated product. The substrate is selected from... The deuterated product is selected from The other catalysts are optionally absent, or selected from halogen catalysts or Ni catalysts; Among them, R 1 Selected from alkyl, -C(=O)-R 5 、-(CR 6 2) n -O-aryl-O-aryl, -(CR 6 2) n -C(=O)-O-cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 ;R 3 Selected from hydrogen, alkyl, -C(=O)-R 5 ; or R 1 and R 3 Together with the atoms attached to them, they form a heterocycle of 5 to 10 ring atoms, preferably a heterocycle of 5, 6, 7, 8, 9, or 10 ring atoms; R 2 Selected from -C(=O)-R 5 -C(=O)OR 5 aryl, -C(=O)-NH-R 5 ;R 6 Selected from hydrogen or alkyl groups; n is an integer from 0 to 20; R 4 Selected from haloalkyl, alkyl, -C(=O)-R 5 、-(CR 6 2) n -OH, -(CR) 6 2) n -C(=O)-OH、-(CR 6 2) n -C(=O)-NH-R 5 、-(CR 6 2) n -NH-C(=O)-R 5 -OC(=O)-R 5 、-(CR 6 2) n -O-aryl-O-aryl, -(CR 6 2) n -C(=O)-O-cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 ; or R 4 It forms a ring of 5 to 15 ring atoms with the C atom on Ar; the R 5 Selected from C 1-20 Alkyl, -CN, -O-alkyl, cycloalkyl, -NH-alkyl, -Ar-Ar, aryl or heteroaryl; Ar is selected from aryl or heteroaryl; The alkyl, heterocyclic, cyclic, cycloalkyl, aryl, and heteroaryl groups with 5 to 15 ring atoms may be further substituented with the same or different -R groups. 7 Mono- or poly-substituted, wherein the substituent R 7 Selected from hydrogen, deuterium, fluorine, chlorine, bromine, iodine, -CN, -OH, -C(=O)OH, -C(=O)-NH-alkyl, -NH-C(=O)-alkyl, haloalkyl, alkyl, -C(=O)O-alkyl, -(CR 6 2) n -C(=O)OH, -(CR) 6 2) n -C(=O)O-alkyl, -C(=O)-alkyl, -OC(=O)-alkyl, -O-alkyl, -B(pin), -OTBS, -C(=O)O-aryl, -C(=O)-aryl, -OC(=O)-aryl, -O-aryl, -NHC(=O)-aryl, aryl, aryl-OC(=O)-alkyl, aryl-C(=O)O-alkyl, heteroaryl-aryl-S(=O)2-NH2, heterocyclic or heteroaryl.
2. The method according to claim 1, characterized in that, The photocatalyst is an iridium photosensitizer; or, optionally, the iridium photosensitizer is selected from Ir[dF(CF3)ppy]2(dtbbpy)PF6; or, optionally, the halogen catalyst is selected from at least one of NaBr and NiBr2·glyme; or, optionally, the Ni catalyst is NiBr2·glyme.
3. The method according to claim 1, characterized in that, The sulfur reagent is selected from disulfide or L-cysteine derivatives; or optionally, the sulfur reagent is selected from... At least one of them; Optionally, the solvent is selected from at least one of ethyl acetate, isopropyl acetate, ethanol, methanol, cyclohexane, n-hexane, n-pentane, n-heptane, petroleum ether, gasoline, diethyl ether, tetrahydrofuran, dichloromethane, chloroform, deuterated chloroform, carbon tetrachloride, 1,2-dichloroethane, ethyl acetate, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and deuterated acetonitrile; or optionally, in step S1, a ligand may be added, preferably, the ligand is selected from dtbbpy; or optionally, the deuterium source is selected from at least one of deuterium gas, deuterated water, deuterated iodomethane, deuterated methanol, deuterated ethanol, deuterated benzene, and deuterated lithium aluminum.
4. The method according to claim 1, characterized in that, The illumination uses a blue LED lamp with a wavelength of 30-40W and a wavelength of 400-450nm, preferably 427nm; or optionally, the heating temperature is 50-90℃, preferably 60-80℃; or optionally, the reaction time in step S3 is 48-72 hours.
5. The method according to claim 1, characterized in that, The molar amount of the photocatalyst is 1-4 mol%; or optionally, the molar ratio of the other catalysts to the substrate is 1.5-2:1; or optionally, the molar amount of the sulfur reagent is 10-15 mol%; or optionally, the amount of the ligand is 10-15 mol%; or optionally, the amount of the halogen catalyst is 10-15 mol%; or optionally, the post-treatment refers to column chromatography separation after the reaction is completed.
6. The method according to claim 1, characterized in that, R 1 Selected from C 1-20 Alkyl, -C(=O)-R 5 、-(CR 6 2) n -OC 6-20 Aryl-OC 6-20 Aryl, -(CR 6 2) n -C(=O)-OC 3-10 cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 ; or optionally, R 1 Selected from C 1-10 Alkyl, -C(=O)-R 5 、-(CR 6 2) n -OC 6-12 Aryl-OC 6-12 Aryl, -(CR 6 2) n -C(=O)-OC 3-10 cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS、-(CR 6 2) n -C(=O)OR 5 ; or optionally, R 3 Selected from hydrogen, C 1-10 Alkyl, -C(=O)-R 5 ; or optionally, R 1 and R 3 The atoms bonded to them together form heterocycles with 5, 6, 7, 8, 9, or 10 ring atoms, preferably:
7. The method according to claim 1, characterized in that, R 2 Selected from -C(=O)-R 5 -C(=O)OR 5 C 6-12 Aryl, -C(=O)-NH-R 5 ; Or optionally, R 6 Selected from hydrogen or C 1-20 alkyl.
8. The method according to claim 1, characterized in that, Ar is selected from C 6-20 Aryl or C 1-20 heteroaryl; or optionally, Ar is selected from Thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, pyridinyl, pyridinyl, triazinyl, tetraazinyl, indolyl, benzothiopheneyl, benzofuranyl, benzimidazolyl, inzolyl, benzotriazolyl, benzothiazolyl, benzothiadiazolyl, benzooxazolyl, isomerized quinolinyl, isomerized isoquinolinyl, phthalazinyl, quinoxolinyl, quinazolinyl, cinolinyl, or naphthinyl; Or optionally, R 4 Selected from C 1-20 Haloalkyl, C 1-20 Alkyl, -C(=O)-R 5 、-(CR 6 2) n -OH, -(CR) 6 2) n -C(=O)-OH、-(CR 6 2) n -C(=O)-NH-R 5 、-(CR 6 2) n -NH-C(=O)-R 5 -OC(=O)-R 5 、-(CR 6 2) n -OC 6-20 Aryl-OC 6-20 Aryl, -(CR 6 2) n -C(=O)-OC 3-10 cycloalkyl, -(CR 6 2) n -OC(=O)-R 5 、-(CR 6 2) n -OTBS or -(CR) 6 2) n -C(=O)OR 5 ; or R 4 Forming with C atoms on Ar Alternatively, the R 5 Selected from C 1-20 Alkyl, -CN, -OC 1-20 Alkyl, C 3-10 cycloalkyl, -NH-C 1-20 Alkyl, -C 6-20 Aryl-C 1-20 heteroaryl, -C 6-20 Aryl C 6-20 Aryl, C 6-20 Aryl or C 1-20 Mixed aromatic compounds.
9. The method according to claim 1, characterized in that, The substrate is selected from one of the following structures: The deuterated product is selected from one of the following structures:
10. A method for preparing a deuterated ibuprofen compound, characterized in that, It is prepared using the preparation method described in any one of claims 1 to 9.
